Results 201 to 210 of about 15,814 (215)
Some of the next articles are maybe not open access.

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care

Circulation, 2019
Anouk Déruaz-Luyet   +2 more
exaly  

Empagliflozin Directly Improves Diastolic Function in Human Heart Failure

European Journal of Heart Failure, 2018
Katrin Streckfuss-Bömeke   +1 more
exaly  

The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

Biochemical and Biophysical Research Communications, 2020
Adrian Quan, Kim Connelly
exaly  

Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes

Diabetes Research and Clinical Practice, 2015
Hans-Juergen Woerle   +2 more
exaly  

Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study

Clinical Endocrinology, 2019
Alan S Rigby   +2 more
exaly  

Home - About - Disclaimer - Privacy